Cargando…
Efficacy, safety and effect on gene expression profiling of anakinra in systemic-onset juvenile idiopathic arthritis: final results of a randomised, double-blind, placebo-controlled trial (ANAJIS)
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334078/ http://dx.doi.org/10.1186/1546-0096-6-S1-P27 |
_version_ | 1782230584999804928 |
---|---|
author | Quartier, P Allantaz, F Cimaz, R Pillet, P Richer, O Desjonqueres, M Duquesne, A Messiaen, C Bardin, C Bossuyit, X Boutten, A Bienvenu, J Menoni, V Sotou-Bere, S Neven, B Mahloui, N Mogenet, A Kassai, B Chaussabel, D Treluyer, JM Bresson, JL Landais, P Pascual, V |
author_facet | Quartier, P Allantaz, F Cimaz, R Pillet, P Richer, O Desjonqueres, M Duquesne, A Messiaen, C Bardin, C Bossuyit, X Boutten, A Bienvenu, J Menoni, V Sotou-Bere, S Neven, B Mahloui, N Mogenet, A Kassai, B Chaussabel, D Treluyer, JM Bresson, JL Landais, P Pascual, V |
author_sort | Quartier, P |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-3334078 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-33340782012-04-24 Efficacy, safety and effect on gene expression profiling of anakinra in systemic-onset juvenile idiopathic arthritis: final results of a randomised, double-blind, placebo-controlled trial (ANAJIS) Quartier, P Allantaz, F Cimaz, R Pillet, P Richer, O Desjonqueres, M Duquesne, A Messiaen, C Bardin, C Bossuyit, X Boutten, A Bienvenu, J Menoni, V Sotou-Bere, S Neven, B Mahloui, N Mogenet, A Kassai, B Chaussabel, D Treluyer, JM Bresson, JL Landais, P Pascual, V Pediatr Rheumatol Online J Poster Presentation BioMed Central 2008-09-15 /pmc/articles/PMC3334078/ http://dx.doi.org/10.1186/1546-0096-6-S1-P27 Text en Copyright ©2008 Quartier et al; licensee BioMed Central Ltd. |
spellingShingle | Poster Presentation Quartier, P Allantaz, F Cimaz, R Pillet, P Richer, O Desjonqueres, M Duquesne, A Messiaen, C Bardin, C Bossuyit, X Boutten, A Bienvenu, J Menoni, V Sotou-Bere, S Neven, B Mahloui, N Mogenet, A Kassai, B Chaussabel, D Treluyer, JM Bresson, JL Landais, P Pascual, V Efficacy, safety and effect on gene expression profiling of anakinra in systemic-onset juvenile idiopathic arthritis: final results of a randomised, double-blind, placebo-controlled trial (ANAJIS) |
title | Efficacy, safety and effect on gene expression profiling of anakinra in systemic-onset juvenile idiopathic arthritis: final results of a randomised, double-blind, placebo-controlled trial (ANAJIS) |
title_full | Efficacy, safety and effect on gene expression profiling of anakinra in systemic-onset juvenile idiopathic arthritis: final results of a randomised, double-blind, placebo-controlled trial (ANAJIS) |
title_fullStr | Efficacy, safety and effect on gene expression profiling of anakinra in systemic-onset juvenile idiopathic arthritis: final results of a randomised, double-blind, placebo-controlled trial (ANAJIS) |
title_full_unstemmed | Efficacy, safety and effect on gene expression profiling of anakinra in systemic-onset juvenile idiopathic arthritis: final results of a randomised, double-blind, placebo-controlled trial (ANAJIS) |
title_short | Efficacy, safety and effect on gene expression profiling of anakinra in systemic-onset juvenile idiopathic arthritis: final results of a randomised, double-blind, placebo-controlled trial (ANAJIS) |
title_sort | efficacy, safety and effect on gene expression profiling of anakinra in systemic-onset juvenile idiopathic arthritis: final results of a randomised, double-blind, placebo-controlled trial (anajis) |
topic | Poster Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334078/ http://dx.doi.org/10.1186/1546-0096-6-S1-P27 |
work_keys_str_mv | AT quartierp efficacysafetyandeffectongeneexpressionprofilingofanakinrainsystemiconsetjuvenileidiopathicarthritisfinalresultsofarandomiseddoubleblindplacebocontrolledtrialanajis AT allantazf efficacysafetyandeffectongeneexpressionprofilingofanakinrainsystemiconsetjuvenileidiopathicarthritisfinalresultsofarandomiseddoubleblindplacebocontrolledtrialanajis AT cimazr efficacysafetyandeffectongeneexpressionprofilingofanakinrainsystemiconsetjuvenileidiopathicarthritisfinalresultsofarandomiseddoubleblindplacebocontrolledtrialanajis AT pilletp efficacysafetyandeffectongeneexpressionprofilingofanakinrainsystemiconsetjuvenileidiopathicarthritisfinalresultsofarandomiseddoubleblindplacebocontrolledtrialanajis AT richero efficacysafetyandeffectongeneexpressionprofilingofanakinrainsystemiconsetjuvenileidiopathicarthritisfinalresultsofarandomiseddoubleblindplacebocontrolledtrialanajis AT desjonqueresm efficacysafetyandeffectongeneexpressionprofilingofanakinrainsystemiconsetjuvenileidiopathicarthritisfinalresultsofarandomiseddoubleblindplacebocontrolledtrialanajis AT duquesnea efficacysafetyandeffectongeneexpressionprofilingofanakinrainsystemiconsetjuvenileidiopathicarthritisfinalresultsofarandomiseddoubleblindplacebocontrolledtrialanajis AT messiaenc efficacysafetyandeffectongeneexpressionprofilingofanakinrainsystemiconsetjuvenileidiopathicarthritisfinalresultsofarandomiseddoubleblindplacebocontrolledtrialanajis AT bardinc efficacysafetyandeffectongeneexpressionprofilingofanakinrainsystemiconsetjuvenileidiopathicarthritisfinalresultsofarandomiseddoubleblindplacebocontrolledtrialanajis AT bossuyitx efficacysafetyandeffectongeneexpressionprofilingofanakinrainsystemiconsetjuvenileidiopathicarthritisfinalresultsofarandomiseddoubleblindplacebocontrolledtrialanajis AT bouttena efficacysafetyandeffectongeneexpressionprofilingofanakinrainsystemiconsetjuvenileidiopathicarthritisfinalresultsofarandomiseddoubleblindplacebocontrolledtrialanajis AT bienvenuj efficacysafetyandeffectongeneexpressionprofilingofanakinrainsystemiconsetjuvenileidiopathicarthritisfinalresultsofarandomiseddoubleblindplacebocontrolledtrialanajis AT menoniv efficacysafetyandeffectongeneexpressionprofilingofanakinrainsystemiconsetjuvenileidiopathicarthritisfinalresultsofarandomiseddoubleblindplacebocontrolledtrialanajis AT sotouberes efficacysafetyandeffectongeneexpressionprofilingofanakinrainsystemiconsetjuvenileidiopathicarthritisfinalresultsofarandomiseddoubleblindplacebocontrolledtrialanajis AT nevenb efficacysafetyandeffectongeneexpressionprofilingofanakinrainsystemiconsetjuvenileidiopathicarthritisfinalresultsofarandomiseddoubleblindplacebocontrolledtrialanajis AT mahlouin efficacysafetyandeffectongeneexpressionprofilingofanakinrainsystemiconsetjuvenileidiopathicarthritisfinalresultsofarandomiseddoubleblindplacebocontrolledtrialanajis AT mogeneta efficacysafetyandeffectongeneexpressionprofilingofanakinrainsystemiconsetjuvenileidiopathicarthritisfinalresultsofarandomiseddoubleblindplacebocontrolledtrialanajis AT kassaib efficacysafetyandeffectongeneexpressionprofilingofanakinrainsystemiconsetjuvenileidiopathicarthritisfinalresultsofarandomiseddoubleblindplacebocontrolledtrialanajis AT chaussabeld efficacysafetyandeffectongeneexpressionprofilingofanakinrainsystemiconsetjuvenileidiopathicarthritisfinalresultsofarandomiseddoubleblindplacebocontrolledtrialanajis AT treluyerjm efficacysafetyandeffectongeneexpressionprofilingofanakinrainsystemiconsetjuvenileidiopathicarthritisfinalresultsofarandomiseddoubleblindplacebocontrolledtrialanajis AT bressonjl efficacysafetyandeffectongeneexpressionprofilingofanakinrainsystemiconsetjuvenileidiopathicarthritisfinalresultsofarandomiseddoubleblindplacebocontrolledtrialanajis AT landaisp efficacysafetyandeffectongeneexpressionprofilingofanakinrainsystemiconsetjuvenileidiopathicarthritisfinalresultsofarandomiseddoubleblindplacebocontrolledtrialanajis AT pascualv efficacysafetyandeffectongeneexpressionprofilingofanakinrainsystemiconsetjuvenileidiopathicarthritisfinalresultsofarandomiseddoubleblindplacebocontrolledtrialanajis |